Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell 3000 Growth Index
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.565 USD | +4.41% | +0.73% | -1.95% |
03-14 | Monte Rosa Therapeutics Q4 Net Loss Narrows; Shares Decline | MT |
03-14 | Monte Rosa Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.95% | 268M | |
+2.16% | 42.75B | |
+47.75% | 41.61B | |
+12.03% | 41.34B | |
-12.36% | 26.59B | |
+8.11% | 25.49B | |
-23.50% | 18.12B | |
+30.25% | 12.24B | |
-1.90% | 11.76B | |
+8.10% | 11B |
- Stock Market
- Equities
- GLUE Stock
- News Monte Rosa Therapeutics, Inc.
- Monte Rosa Therapeutics, Inc.(NasdaqGS: GLUE) dropped from Russell 3000 Growth Index